The popularity of copyright’s blockbuster initially fueled a period of growth for the drug industry, but recent shifts present a complicated outlook for shareholders. Off-patent alternatives are eroding profits, and https://deweyebna475204.weblogco.com/41471653/sildenafil-and-pharma-a-risky-bet